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Modification of the 1-Phosphate Group during Biosynthesis of
Capnocytophaga canimorsus Lipid A
Francesco Renzi,a Ulrich Zähringer,b Courtney E. Chandler,c Robert K. Ernst,c Guy R. Cornelis,a,d Simon J. Ittigd
Université de Namur, Namur, Belgiuma; Division of Immunochemistry, Research Center Borstel, Leibniz Center for Medicine and Biosciences, Borstel, Germanyb;
Department of Microbial Pathogenesis, University of Maryland, Baltimore, Maryland, USAc; Biozentrum der Universität Basel, Basel, Switzerlandd
Capnocytophaga canimorsus, a commensal bacterium of dog’s mouth flora causing severe infections in humans after dog bites
or scratches, has a lipopolysaccharide (LPS) (endotoxin) with low-inflammatory lipid A. In particular, it contains a phosphoe-
thanolamine (P-Etn) instead of a free phosphate group at the C-1 position of the lipid A backbone, usually present in highly toxic
enterobacterial Gram-negative lipid A. Here we show that the C. canimorsus genome comprises a single operon encoding a lipid
A 1-phosphatase (LpxE) and a lipid A 1 P-Etn transferase (EptA). This suggests that lipid A is modified during biosynthesis after
completing acylation of the backbone by removal of the 1-phosphate and subsequent addition of an P-Etn group. As endotoxic-
ity of lipid A is known to depend largely on the degree of unsubstituted or unmodified phosphate residues, deletion of lpxE or
eptA led to mutants lacking the P-Etn group, with consequently increased endotoxicity and decreased resistance to cationic anti-
microbial peptides (CAMP). Consistent with the proposed sequential biosynthetic mechanism, the endotoxicity and CAMP re-
sistance of a double deletion mutant of lpxE-eptA was similar to that of a single lpxE mutant. Finally, the proposed enzymatic
activities of LpxE and EptA based on sequence similarity could be successfully validated by mass spectrometry (MS)-based analy-
sis of lipid A isolated from the corresponding deletion mutant strains.
Some Gram-negative bacteria have evolved different modifica-tions of their lipid A structure, leading to a reduced recogni-
tion by the host and sensitivity to cationic antimicrobial peptides
(CAMP) (1–7). One of these modifications occurs on the 1- or
4=-phosphate of lipid A (1, 4, 7–10). 4=-Phosphatases (LpxF) have
been reported in Rhizobium leguminosarum, Rhizobium etli, Por-
phyromonas gingivalis, Francisella species, and Helicobacter pylori
(1, 10–12). Deletion of lpxF and the resulting presence of the 4=-
phosphate on lipid A leads to increased endotoxicity (1, 12) and
decreased resistance to CAMP (10, 12). In the case of Francisella
and H. pylori, virulence is reduced (11, 12, 13). 1-Phosphatases
(LpxE) have been identified in H. pylori, P. gingivalis, R. etli, and
others (1, 6, 10, 12, 14–16). Deletion of lpxE and the resulting
presence of the 1-phosphate on lipid A leads to a slightly increased
endotoxicity (1) and CAMP sensitivity (10). InH. pylori, position
1 is further modified by the addition of a phosphoethanolamine
(P-Etn) (15, 17, 18), a modification known from other bacteria
(15, 17, 18). This happens via a two-step mechanism, which first
involves dephosphorylation of one phosphate residue located at
position C-1 of the lipid A backbone by LpxE and subsequent
P-Etn transfer by a phosphoethanolamine transferase (EptA or
PmrC) (15, 16). In H. pylori, lpxE and eptA are contained in one
operon (Hp0021-Hp0022) (16).
We have previously characterized the lipid A structure of Cap-
nocytophaga canimorsus (19), a bacterial species that can cause
rare but severe sepsis or meningitis in humans after dog bites or
scratches (20–24). C. canimorsus belongs to the family Flavobac-
teriaceae in the phylum Bacteroidetes and is a usual member of
dog’s mouth flora (21, 25–28). C. canimorsus lipid A consists of a
2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N=)-(1=¡6)-linked
to 2-amino-2-deoxy-D-glucose (GlcN) [-D-GlcpN3N=-(1¡6)-
D-GlcpN lipid A hybrid backbone] containing an P-Etn group
attached to the C-1 reducing end and lacking a 4=-phosphate (Fig.
1A). 3-Hydroxy-15-methylhexadecanoic acid [i17:0(3-OH)],
3-hydroxy-13-methyltetradecanoic acid [i15:0(3-OH)], 3-O-(13-
methyltetradecanoyl)-15-methylhexadecanoic acid [i17:0[3-
O(i15:0)]], and 3-hydroxyhexadecanoic acid [16:0(3-OH)] are at-
tached to the backbone at positions 2, 3, 2=, and 3=, respectively
(19). This structure differs from that of a potent Toll-like receptor
4 (TLR4) agonist like the Escherichia coli lipid A (Fig. 1B), consist-
ing of a -(1=¡6)-linked GlcN disaccharide that is phosphory-
lated at positions 1 and 4= and carries four (R)-3-hydroxymyr-
istate chains [14:0(3-OH)] (at positions 2=, 3=, 2, and 3). The 2=
and 3= 3-hydroxylated acyl groups in GlcN(II) are further esteri-
fied with laurate and myristate, respectively (29).
We have identified lpxE and eptA genes in the genome of C.
canimorsus and found the overlapping genes to be organized in
one operon. We show that the deletion of lpxE or eptA leads to
increased endotoxicity and decreased resistance to CAMP, where
deletion of lpxE has a more severe effect. Interestingly, the endo-
toxicity and CAMP resistance of a double deletion mutant of lpxE
and eptA were the same as those of a single lpxE mutant. This
suggests that the P-Etn-containing lipid A is synthesized by a sim-
ilar two-step enzymatic process as inH. pylori, where dephosphor-
ylation is necessary for substitution of 1-phosphate with P-Etn.
Finally, we could successfully validate the proposed lipid A struc-
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tures of the respective deletion mutants by mass spectrometry
(MS) analysis, thus also further confirming, on a structural basis,
the proposed enzymatic activities of LpxE and EptA as well as the
two-step enzymatic mechanism in the lipid A biosynthesis.
MATERIALS AND METHODS
Bacterial strains and growth conditions.Thebacterial strains used in this
study are listed in Table 1. Escherichia coli strains were grown in LB broth
at 37°C. Capnocytophaga canimorsus strain 5 (Cc5) (30) was routinely
grown on heart infusion agar (HIA; Difco) supplemented with 5% sheep
blood (Oxoid) for 2 days at 37°C in the presence of 5%CO2. Bacteria were
harvested by scraping colonies off the agar surface, washed, and resus-
pended in phosphate-buffered saline (PBS). The following selective
agents were added at the concentrations indicated: erythromycin, 10 g/
ml; cefoxitin, 10 g/ml; gentamicin, 20 g/ml; ampicillin, 100 g/ml;
tetracycline, 10 g/ml.
Genetic manipulations of C. canimorsus. Genetic manipulations of
wild-type (wt) Cc5 have been described (31). Briefly, replacement cas-
settes with flanking regions spanning approximately 500 bp homologous
to regions directly adjacent to the lpxE or eptA gene (28) were constructed
with a three-fragment overlapping PCR strategy. As the ATG codon of the
eptA gene is located within the coding region of lpxE, 106 bp upstream of
the eptA ATG codon was not deleted in an lpxE single knockout (
1833737-1833995). First, two PCRs were performed on 100 ng of Cc5
genomic DNA with primers A and B (Table 2) for the upstream flanking
regions and with primers E and F for the downstream regions. Primers B
and E contained an additional 5= 20-nucleotide extension homologous to
the ermF or tetQ insertion cassette. The ermF and tetQ resistance cassettes
were amplified from plasmids pMM13 and pMM104.A DNA, respec-
tively, with primers C and D. All three PCR products were cleaned and
then mixed in equal amounts for PCR using Phusion polymerase
(Finnzymes). The initial denaturation was at 98°C for 2 min, followed by
12 cycles without primers to allow annealing and elongation of the over-
lapping fragments (1 cycle consists of 98°C for 30 s, 50°C for 40 s, and 72°C
for 2 min). After the addition of external primers (primers A and F), the
program was continued with 20 cycles (1 cycle consists of 98°C for 30 s,
50°C for 40 s, and 72°C for 2 min 30 s) and finally 10 min at 72°C. Final
PCR products containing lpxE::ermF, eptA::ermF, lpxE-eptA::ermF, lpxE::
tetQ, eptA::tetQ, or lpxE-eptA::tetQ insertion cassettes were then digested
with PstI and SpeI for cloning into the appropriate sites of theC. canimor-
sus suicide vector pMM25 (31). The resulting plasmids were transferred
by RP4-mediated conjugative DNA transfer from E. coli S17-1 to C. cani-
morsus strain 5 or C. canimorsus strain 5 Y1C12 mutant to allow integra-
tion of the insertion cassette. Transconjugants were then selected for the
presence of the ermF or tetQ cassette on erythromycin- or tetracycline-
containing plates, respectively, and checked for sensitivity to cefoxitin.
Deletion of the appropriate regions was verified by PCR.
Construction of complementation plasmids.Plasmid pMM47.Awas
used for expression of LpxE and EptA (31). Full-length lpxE, eptA, or
lpxE-eptA genes were amplified with the specific primers listed in Table 2
and cloned into plasmid pMM47.A using NcoI and XbaI or NcoI and
XhoI restriction sites, leading to the insertion of a glycine at position 2.
Ligated plasmids were cloned in E. coli TOP10.
Human TLR4 activation assay. HEK293 cells stably expressing hu-
man Toll-like receptor 4 (hTLR4), myeloid differentiation factor 2 (MD-
2), cluster of differentiation antigen 14 (CD14), and a NF-B-dependent
reporter (secreted embryonic alkaline phosphatase) were from InvivoGen
(HekBlue human TLR4). Growth conditions and endotoxicity assay were
as recommended by the supplier (InvivoGen). Briefly, the desired
amounts of heat-killed bacteria were placed in a total volume of 20 l
(diluted in PBS) and distributed in a flat-bottom 96-well plate (BD Fal-
con). A total of 25,000 HekBlue human TLR4 cells in 180 l were then
added to each well, and the plate was incubated for 20 to 24 h at 37°C and
5% CO2. Detection of the secreted phosphatase followed the QUANTI-
Blue protocol (InvivoGen). The challenged cells (20 l) were incubated
with 180 l detection reagent (QUANTI-Blue; InvivoGen). The plates
were incubated at 37°C and 5%CO2, and absorbancewasmeasured at 655
nm using a spectrophotometer (Bio-Rad).
Polymyxin B sensitivity assay. Polymyxin B sulfate was obtained
from Sigma-Aldrich. The MIC was determined by the agar dilution
FIG 1 Structures of C. canimorsus strain 5 and E. coli lipid A. (A) C. canimorsus strain 5 lipid A consists of a -(1=¡6)-linked GlcN3N=-GlcN disaccharide, to
which 3-hydroxy-15-methylhexadecanoic acid, 3-hydroxy-13-methyltetradecanoic acid, 3-O-(13-methyltetradecanoyl)-15-methylhexadecanoic acid, and
3-hydroxyhexadecanoic acid are attached at positions 2, 3, 2=, and 3=, respectively. The disaccharide carries a positively charged ethanolamine at the 1-phosphate
and lacks a 4=-phosphate (19). (B)E. coli hexa-acylated lipidA consisting of a-(1=¡6)-linkedGlcNdisaccharide that is phosphorylated at positions 1 and 4= and
carries four (R)-3-hydroxymyristate chains (at positions 2=, 3=, 2, and 3). The 2= and 3= 3-hydroxylated acyl groups inGlcN= are further esterifiedwith laurate and
myristate, respectively (29).
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method based on the CLSI/NCCLS recommendations (32). Briefly, 104
bacteria contained in 2l PBS were spotted on HIA plates containing 5%
sheep blood and polymyxin B ranging from 0.5 mg/liter to 1,024 mg/liter
(2-fold increase per step). The plates were incubated and examined for
growth of visible colonies after 48 h and 72 h.
Genome annotation. The Blast-p search tool (33) against the C. cani-
morsus 5 genome (28) was used. Search sequences were obtained from the
National Center for Biotechnology Information. All available Bacte-
roidetes group sequences were used in the search, but standard E. coli
sequences have also been included. The highest scoring subjects over all
the searches have been annotated as corresponding enzymes. Difficulties
in annotation were observed only for lpxE. The lpxE search was based on
lpxF and/or lpxE protein sequences from Porphyromonas gingivalis (1),
Francisella novicida (7), Rhizobium etli (10), Helicobacter pylori (12, 16)
and on all available Bacteroidetes group pgpB protein sequences.
Preparation of bacteria for LPS extraction. Compositional analysis
of the lipopolysaccharide (LPS) from the wt C. canimorsus 5 strain previ-
ously showed that it was highly contaminated with glucose from amyl-
opectin, flavolipin, and capnin, known to be present in Capnocytophaga
spp. and Flavobacteriaceae (34). In contrast, the LPS from theC. canimor-
sus 5 Y1C12 mutant (35) was devoid of such contaminating material.
Since compositional analysis of the lipidA andLPS core obtained from the
wt strain LPS and that of the Y1C12 mutant revealed no differences with
respect to their sugars and fatty acids (19, 34), the Y1C12 mutant was
chosen as the background strain to isolate and analyze the lipid A of
eptA, lpxE, and lpxE-eptA deletion mutants in detail by MS analysis.
While the Y1C12 mutant was chosen as the background strain for MS
analysis, please note that human TLR4 activation assays and polymyxin B
sensitivity analysis are based onC. canimorsus 5eptA,lpxE, andlpxE-
eptA deletion mutants and complemented mutants based on these dele-
tionmutants. The C. canimorsus 5-based Y1C12mutant has a transposon
insertion within a predicted glycosyltransferase-encoding gene, probably
theN-acetyl fucosamine transferaseWbuB, necessary for the formation of
the O antigen (35). Endotoxicity of resulting C. canimorsus 5 Y1C12
eptA, lpxE, and lpxE-eptA deletion mutants was assessed, and the
results confirmed results obtainedwithC. canimorsus 5eptA,lpxE, and
lpxE-eptA deletion mutants (data not shown). C. canimorsus bacteria
were harvested from 25 blood plates in PBS, followed by centrifugation at
18,000 g for 30 min. Bacteria were resuspended in cold acetone, incu-
bated with shaking, resuspended in PBS containing 0.5% phenol for kill-
ing, again harvested by centrifugation, washedwith PBS, and resuspended
in 1 ml water. One tenth of the volume was plated on appropriate growth
plates to ensure complete bacterial killing. Bacteria were air dried prior to
LPS extraction.
Purification and isolation of free lipid A suitable for MS analysis.
Lipid A was isolated from lyophilized C. canimorsus cell pellets following
the extraction method of El Hamidi et al. (36). Briefly, pellets were dis-
solved in 70% isobutyric acid and 1 M ammonium hydroxide and incu-
bated at 100°C for 1 h. Four hundred microliters of water was added to
each sample, and the samples were snap-frozen on dry ice and lyophilized
overnight. The samples were then washed twice with 1 ml methanol and
reconstituted in 150 l chloroform-methanol-water (3:1.5:0.25, vol/vol/
vol).
MS-based structural analysis. Lipid A structures were assessed by
negative- and positive-ion matrix-assisted laser desorption ionization–
time of flight mass spectrometry (MALDI-TOF MS). Lyophilized lipid A
was extracted in chloroform-methanol, and then 1l wasmixedwith 1l
of norharmane MALDI matrix. All MALDI-TOF MS experiments were
performed using a Bruker Microflex MALDI-TOF mass spectrometer
(Bruker Daltonics, Billerica, MA). Each spectrum was an average of 300
shots. Electrospray (ES) tuning mix (Agilent, Palo Alto, CA) was used for
TABLE 1 Bacterial strains and plasmids used in this study
Strain and genotype or
plasmid Origin, construction, description, or relevant genotype and/or phenotype Reference
Strains
Cc5 Isolated from a case of human fatal septicemia after a dog bite in 1995 30
Cc5 lpxE Replacement of Ccan_16960 by ermF; Emr (primers 6493 to 6498) ( 1833737-1833995) This study
Cc5 eptA Replacement of Ccan_16950 by ermF; Emr (primers 6499 to 6504) ( 1831370-1832888) This study
Cc5 lpxE-eptA Replacement of Ccan_16960-16950 by ermF; Emr (primers 6493 to 6495 and 6502 to 6504)
( 1831370-1833995)
This study
Cc5 Y1C12 Tn4351 insertion in Ccan_23370, “wbuB”-like glycosyltransferase 35
Cc5 Y1C12 lpxE Replacement of Ccan_16960 by tetQ; Tcr (primers 7539 to 7544) ( 1833737-1833995) This study
Cc5 Y1C12 eptA Replacement of Ccan_16950 by tetQ; Tcr (primers 7545 to 7550) ( 1831370-1832888) This study
Cc5 Y1C12 lpxE-eptA Replacement of Ccan_16960-16950 by tetQ; Tcr (primers 7539, 7540, 7543, 7547, 7548, and 7550)
( 1831370-1833995)
This study
Plasmids
p-lpxE pMM47.AlpxE (expression plasmid carrying the complete lpxE gene from Cc5) This study
p-lpxE-eptA pMM47.AlpxE-eptA (expression plasmid carrying the complete lpxE-eptA genes from Cc5) This study
p-eptA pMM47.AeptA (expression plasmid carrying the complete eptA gene from Cc5) This study
pMM13 ColE1 ori; Apr (Emr); ermF from pEP4351 31
pMM25 ColE1 ori; Kmr (Cfr); suicide vector for C. canimorsus 31
pMM47.A ColE1 ori (pCC7 ori); Apr (Cfr); E. coli-C. canimorsus expression shuttle plasmid. C. canimorsus expression
is driven by an ermF promoter.
31
pMM104.A ColE1 ori (pCC7 ori); Apr (Tcr); E. coli-C. canimorsus shuttle plasmid, RP4 oriT. The PstI fragment of
pMM47.A containing repA was inserted into the PstI site of pLYL001.
31
pSI73 pMM25lpxE::ermF (suicide vector for deletion of lpxE [ 1833737-1833995]) This study
pSI74 pMM25eptA::ermF (suicide vector for deletion of eptA [ 1831370-1832888]) This study
pSI76 pMM25lpxE-eptA::ermF (suicide vector for deletion of lpxE-eptA [ 1831370-1833995]) This study
pFR28 pMM25lpxE::tetQ (suicide vector for deletion of lpxE [ 1833737-1833995]) This study
pFR29 pMM25eptA::tetQ (suicide vector for deletion of eptA [ 1831370-1832888]) This study
pFR30 pMM25lpxE-eptA::tetQ (suicide vector for deletion of lpxE-eptA [ 1831370-1833995]) This study
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calibration. Data were analyzed using Bruker Daltonik flexAnalysis soft-
ware.
Immunoblotting of proteinase K-resistant structures. Bacteria were
harvested from blood agar plates, washed once in 1 ml of PBS, and ad-
justed to an optical density at 600 nm (OD600) of 1.5 in PBS. Five hundred
microliters of bacterial suspension was pelleted and dissolved in 125 l
loading buffer (1% sodium dodecyl sulfate [SDS], 10% glycerol, 50 mM
dithiothreitol, 0.02% bromophenol blue, 45mMTris [pH 6.8] in double-
distilled water [ddH2O]). Samples were boiled at 99°C for 10min. Protei-
nase K (final concentration of 50 g/ml) was added, and samples were
incubated at 37°C overnight. After incubation, samples were boiled again
for 10min at 99°C, and a second volumeof proteinaseK (equal to the first)
was added. The samples were incubated at 55°C for 3 h, boiled again for 5
min at 99°C, and loaded on a 15% SDS-polyacrylamide gel. The samples
were analyzed by Western blotting using polyclonal, C. canimorsus 5
Y1C12-absorbed serum against C. canimorsus 5. This antibody was gen-
erated from rabbits by immunization with heat-killed C. canimorsus 5
(Laboratoire d’Hormonologie, Marloie, Belgium). The C. canimorsus 5
Y1C12-absorbed serum was prepared by incubating twice an excess
amount of Y1C12mutantC. canimorsus 5 bacteria (harvested from blood
agar plates and washed in PBS) with anti-C. canimorsus 5 serum at 4°C for
12 h. Bacteria were removed by repeated centrifugation. This results in an
antiserum recognizing C. canimorsus 5 LPS (35).
RESULTS AND DISCUSSION
Identification of enzymes leading to the presence of 1 P-Etn on
lipid A. The genome of C. canimorsus 5 (28) (GenBank accession
no. CP002113.1) was analyzed for proteins with high sequence
similarity to lipid A-modifying enzymes LpxE and EptA. Our
search for a lipid A phosphatase was based on LpxE and/or LpxF
sequences from P. gingivalis (1), F. novicida (11), R. etli (10), and
H. pylori (12, 16) and on all available Bacteroidetes group
pgpB sequences. Three lpxE or lpxF candidates were found
(Ccan_16960, Ccan_14540, and Ccan_06070) and individually
deleted. Interestingly, the gene downstream of Ccan_16960
(GenBank accession no. YP_004740919.1), Ccan_16950 (Gen-
Bank accession no. YP_004740918.1), was found to have high se-
quence similarity to eptA, coding for a lipid A P-Etn transferase.
Ccan_16950 and Ccan_16960 form an operon, and the two genes
overlap by 20 bp (Fig. 2, bottom). Ccan_16960 has thus been an-
notated as lpxE, an annotation validated bymutagenesis,MS anal-
ysis, and impact on endotoxicity and CAMP resistance, as de-
scribed below. The association of lpxE and eptA genes reinforces
the idea that the two gene products act in the same pathway and
suggests that the modification of lipid A that they determine to-
gether is essential for survival in the environment of a dog’s
mouth.
Predicted lipid A structures in eptA, lpxE, and lpxE-eptA de-
letion mutants. EptA has been proposed not to be active on lipid
A, in case the 1-phosphate has not been removed before by LpxE
(15, 16). Hence, deletion of the lipid A 1-phosphatase LpxE, the
enzyme proposed to act first in this two-step mechanism, should
result in a lipid A having a 1-phosphate (Fig. 2). Upon deletion of
only the second enzyme acting in the pathway, the P-Etn trans-
ferase EptA, a free hydroxy group at the “reducing end” of the lipid
A backbone should result (Fig. 2). This would reflect the fact that
LpxE is still active even in the absence of EptA (15, 16). The result-
ing lipid A in the eptA deletion mutant is thus predicted to lack
both the 4= phosphate and the 1-phosphate. In the case of a lpxE
and eptA double deletion mutant, the same 1-phospho lipid A is
predicted as for the single deletion in lpxE (Fig. 2).
The 1-phospho lipid A variant predicted for lpxE and
lpxE-eptA mutants should be the variant with the highest
endotoxicity. In the case of an eptA deletion mutant, the free
(hydroxy) 4= and 1 position should result in a very low endo-
toxic lipid A, as is known from completely dephosphorylated
synthetic lipid A analogues (37).
LpxE and EptA impact on endotoxicity. To study the endo-
toxic activity after the removal of the 1-phosphate or the addition
of an P-Etn to the free position 1 of lipid A, we engineered eptA
and lpxE mutations and monitored endotoxicity using a
HEK293 cell line overexpressing humanTLR4/MD-2/CD14 and a
secreted reporter protein (HEKBlue human TLR4 cell line). Acti-
vation of this cell line essentially depends on TLR4, and other TLR
stimuli may be neglected. Heat-killed bacteria from both mutant
strains showed increased endotoxicity compared to wt bacteria,
and mutation of lpxE had a more severe impact on endotoxicity
FIG 2 Schematic representation of the proposed enzymatic activity of LpxE, EptA, and LpxF in the biosynthesis of C. canimorsus lipid A (top) and illustration
of the lpxE-eptA operon (drawn to scale) (bottom) corresponding to Ccan_16960 and Ccan_16950, respectively.
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(Fig. 3A). The endotoxicity of heat-killed C. canimorsus lpxE-
eptAmutant was identical to that of the C. canimorsus lpxEmu-
tant (Fig. 3A).
Complementation of the deleted genes with plasmid-borne
genes expressed from the ermF promoter restored endotoxicity to
the wt level, indicating that none of the mutation was polar (Fig.
3B, C, and D). The lpxE strain could be complemented in trans
with lpxE or lpxE-eptA, but not with eptA alone (Fig. 3B). A slight
increase in TLR4 activation of the lpxE strain complemented
with eptA compared to that of the lpxE strain was observed (Fig.
3B). This might be explained by transfer of P-Etn to other parts of
the LPSmolecule, as suggested by sequence similarity to the 3-de-
oxy-D-manno-oct-2-ulosonic acid (Kdo) P-Etn transferase EptB
(38). Finally, the eptA strain was complemented with eptA or
lpxE-eptA (Fig. 3C), and the lpxE-eptA deletion mutant was com-
plemented with lpxE-eptA (Fig. 3D). We conclude from these
complementation experiments that the eptA and lpxE mutations
were nonpolar.
To exclude a strong impact on TLR4 activation uponmutation
of lpxE, eptA, or lpxE and eptA due to various levels of LPS or LPS
made accessible by heat killing, we determined the amount of LPS
in all strains by Western blot experiments on equal amount of
proteinase K-treated bacterial lysates with a C. canimorsus 5 LPS-
specific antiserum (see Fig. S1 in the supplemental material). We
observed similar LPS band intensities for all strains tested, indi-
cating that LPS amounts present in the bacteria and made acces-
sible by heat treatment are not dramatically changed upon muta-
tion of lpxE, eptA, or lpxE and eptA. Notably, a slight size shift of
the LPS band was observed for all strains predicted not to exhibit
a wt lipid A (lpxE, eptA, and lpxE-eptA mutants and lpxE
mutant complemented with a plasmid bearing eptA [lpxE 
p-eptA]). The migration pattern is altered for all strains predicted
not to have the positively charged ethanolamine moiety present,
which might explain this observation.
LpxE and EptA increase resistance to polymyxin B. Lipid A
modifications have been shown to not only affect endotoxicity but
also to alter resistance to CAMP such as polymyxin B (10, 29, 39,
40). Hence, we monitored the MIC of polymyxin B for wt C.
canimorsus,lpxEmutant,eptAmutant, and the double-knock-
out lpxE-eptA strains. The wt C. canimorsus was highly resistant
to polymyxin B, as it was still able to grow in the presence of 512
mg/liter polymyxin B (MIC  1,024 mg/liter) (Fig. 4). The MIC
decreased to 512 mg/liter for eptA mutant bacteria and to 128
mg/liter for thelpxE bacteria, showing an increased sensitivity to
polymyxin B (Fig. 4). The MIC of the C. canimorsus lpxE-eptA
double mutant was the same as that of the single lpxE mutant
(Fig. 4). The lpxE strain could be complemented in trans with
lpxE, but not with eptA alone (Fig. 4). The eptA strain was com-
FIG 3 Effect of lpxE or eptA deletion on endotoxicity. (A) Endotoxicity of heat-killed wild-type C. canimorsus strain 5 (Cc5), lpxE, eptA, or lpxE-eptA
bacteria. The indicatedmultiplicity of infection (Moi) of heat-killed bacteriawas assayed for TLR4-dependentNF-B activationwithHekBlue humanTLR4 cells.
Data were combined from three independent experiments, and the error bars show the standard errors of the means. (B to D) As in panel A but the mutations
were complemented in trans by the indicated plasmids (p-lpxE, plasmid bearing the lpxE gene). All mutations were shown to be nonpolar. Data were combined
from three independent experiments, and the error bars show the standard errors of the means.
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plemented with eptA (Fig. 4), and the lpxE-eptA deletion mutant
was complemented with lpxE-eptA (Fig. 4). We conclude from
these complementation experiments that the lpxE, eptA, and lpxE-
eptAmutations were nonpolar.
TheP-Etnmodification at positionC-1 thus contributed to the
low endotoxicity and polymyxin B resistance of C. canimorsus, as
was shown forH. pylori (12). The identical phenotype in endotox-
icity and polymyxin B sensitivity of the single lpxE and the dou-
blelpxE-eptAmutants suggests that theP-Etn-containing lipidA
is synthesized by a two-step enzymatic process similar to that de-
scribed for H. pylori (15, 16). In H. pylori, lipid A also carries an
P-Etn group at position C-1, generated in the course of the LPS
biosynthesis by removal of the lipid A 1-phosphate by LpxE, fol-
lowed by transfer of an P-Etn residue by EptA from phosphati-
dylethanolamine to the free reducing end of GlcN(I), where de-
phosphorylation is necessary for substitution of 1-phosphate with
P-Etn (12, 15, 16). The nonpolar deletion of lpxE inC. canimorsus
does not prevent the synthesis of EptA but likely leads to a lipid A
with a 1-phosphate group, whichwould explain the high endotox-
icity observed for this strain. Therefore, as in H. pylori, the C.
canimorsus EptA seems to accept only the free reducing end of the
lipid A backbone generated by the activity of LpxE as a substrate.
The lpxE mutation had a more severe effect than the eptA
mutation, bothwith respect to endotoxicity and polymyxin B sen-
sitivity. The difference between the two mutants can be explained
by the fact that EptA adds a negative charge and a positive charge,
whereas LpxE only removes a negative charge. In the two-step
mechanism, thelpxEmutationwould lead to an increase of a neg-
ative charge (the unsubstituted 1-phosphate) compared to the wt,
while theeptAmutationwould result in a free reducing end of lipid
A compared to the P-Etn in the wt. As net negative charges are im-
portant for interactionwith CAMP as well as with TLR4/MD-2 (41),
one would expectlpxE to affect endotoxicity and CAMP sensitivity
more thaneptA, which we found. This again supports the two-step
enzymatic process of formation of the 1 P-Etn.
It is noteworthy that one would expect the mutation of eptA
not to affect any charge-dependent mechanisms, as no net charge
change is expected. C. canimorsus eptA bacteria showed in-
creased endotoxicity and decreased CAMP resistance compared
to bacteria with wt lipid A, while the lipid A variant predicted for
aeptA deletionmutant is lacking both the 1 and 4=-phosphate in
the lipid A backbone. The C. canimorsus 1-dephospho lipid A in a
eptAmutant is not expected to be endotoxic at all, as this lipid A
species lacks both phosphates, and thus, the negative charges that
are important for endotoxicity (41). Still the eptA mutation re-
sulted in a small change in polymyxin B sensitivity and a more
pronounced change in endotoxicity. This hints at a heterogeneous
lipid A population in the eptA strain, which could result from a
restricted activity of LpxE. Assuming a nonstoichiometric activity
of LpxE in the eptA strain, both the lipid A containing a free
reducing end as well as the 1-phosphate at GlcN(I) should be
present. In this case, the 1-phospho lipid A variant could account
for the increase in endotoxicity, while its reduced amounts com-
pared to the lpxEmutant would explain the higher endotoxicity
of the lpxE deletion mutant over the eptA deletion mutant
strain. It might thus be that the accumulation of 1-dephosphoryl-
TABLE 3 MS analysis and interpretation of lipid A variants in wt and
lpxE, eptA, and lpxE-eptA deletion mutant strains
Component or mode
and parameter
Valuea for the
component or
parameter in
the wt
Valuea for the component or
parameter in the following mutant:
lpxE eptA lpxE-eptA
Components
GlcN 1 1 1 1
GlcN3N 1 1 1 1
P 1 1 0 1
Etn 1 0 0 0
i15:0 1 1 1 1
i15:0(3-OH) 1 1 1 1
16:0(3-OH) 1 1 1 1
i17:0(3-OH) 1 1 1 1
Negative-ion mode
Calculatedm/z for the
[M-H] ion
1,716.3 1,673.3 1,575.3 1,673.3
Foundm/z for the
[M-H] ion
1,717 1,674 1,674b 1,674
Positive-ion mode
Calculatedm/z 1,764.3c 1,720.2c 1,603.3d 1,720.2c
Foundm/z 1,764c 1,722c 1,604d 1,722c
a 0 indicates that the component is absent, and 1 indicates that the component is
present once.
b Ion [M-H] detected in the negative-ion mode of lipid A from the eptAmutant was
raised from incomplete dephosphorylated lipid A. The major and representative lipid A
molecule of this mutant lacks any charged group, and therefore, its pseudomolecular
ion [MNa] could be analyzed only in the positive-ion mode.
c Value for the [M-H2Na] ion.
d Value for the [MNa] ion.
FIG 4 Effect of lpxE or eptA deletion on resistance to polymyxin B. The MICs
of polymyxin B for wild-type C. canimorsus strain 5 (Cc5), lpxE, eptA, or
lpxE-eptA and complementedmutants are shown.Datawere combined from
three or four independent experiments, and the measured MICs were always
identical.
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ated lipid A exerts a feedback regulatory effect on the activity of
LpxE, preventing full dephosphorylation in the absence of EptA.
The fraction of 1-phospho lipid A would thus increase, which
would then be responsible for the observed increase in endotox-
icity and sensitivity to polymyxin B.
MS-based structural analysis of eptA, lpxE, and lpxE-eptAde-
letion mutants. In order to validate the enzymatic activities pro-
posed for LpxE and EptA and the predicted two-step enzymatic
mechanism, we performed MS-based structural analysis of iso-
lated lipid A species of the corresponding deletion mutants. One
of the predicted lipidA structures, the 4=- and 1-hydroxy lipidA in
eptA deletion mutant is devoid of any negative charge and thus
not accessible to be analyzed in the negative-ionmode. Therefore,
negative- and positive-ionmodeMSwas run to determine all lipid
A variants expected based on the genetic analysis and endotoxic
activity, respectively.
In the negative-ionmode,MS analysis confirmed thewt lipidA
(calculated m/z, 1,716.3; found m/z, 1,717) (Table 3 and Fig. 5).
Observed mass differences of 14m/z units (m/z of 1,731 or 1,703)
were assigned to acyl chain heterogeneity. For all samples analyzed
by MS, such peak “clusters” differing by 14 m/z units were
found, suggesting that acyl chain heterogeneity was independent
of lpxE or eptAmutagenesis. This is in agreement with our previ-
ous data on wt C. canimorsus lipid A (19, 34).
In the negative-ion mode, all deletion mutant strains
(eptA, lpxE, and lpxE-eptA) showed a main peak at m/z of
1,674 (Table 3 and Fig. 5). The 1-phospho lipid A variant pre-
dicted for lpxE and lpxE-eptA mutant strains has a calcu-
lated m/z of 1,673.3. Hence, eptA, lpxE, and lpxE-eptA
deletion mutant strains feature 1-phospho lipid A.While this is
the variant expected to occur for lpxE and lpxE-eptA strains,
eptA had been predicted to lack the 1-phosphate, thus having
a free reducing end for GlcN(I) in the lipid A backbone (calcu-
lated m/z, 1,575.3). However, due to the lack of a negative
FIG 5 Mass spectrometric analysis of lipid A of the indicated strains as analyzed by MALDI-TOF MS in the negative-ion mode.
C. canimorsus Lipid A Modiﬁcation
February 2016 Volume 84 Number 2 iai.asm.org 557Infection and Immunity
 o
n
 February 10, 2016 by BIBLIO
THEQUE UNIVERSITAIRE
http://iai.asm
.org/
D
ow
nloaded from
 
charged group, this dephospho lipid A variant cannot be ac-
cessed by MS analysis in the negative-ion mode. Nevertheless,
the detection of 1-phospho lipid A as well in the eptA deletion
mutant strain is in perfect agreement with the intermediary
phenotype observed in endotoxicity and CAMP resistance
(Fig. 3 and 4) and the proposed nonstoichiometric activity of
LpxE in the eptA strain.
In order to further confirm the postulated enzymatic mech-
anisms, we performed negative-ion mode MS analysis also on
complemented mutants (see Fig. S2 in the supplemental mate-
rial). The lpxE strain could be complemented in trans with
lpxE, as we confirmed the wt lipid A for the lpxE strain com-
plemented with plasmid bearing lpxE (p-lpxE) (calculatedm/z,
1,716.3; foundm/z, 1,717). The lpxE strain could not be com-
plemented in trans with eptA alone (Fig. S2), and the resulting
strain showed a main peak at m/z of 1,674 (Fig. S2), matching
the 1-phospho lipid A variant predicted for the lpxE strain
(calculatedm/z, 1,673.3). The eptA strain was complemented
with eptA (Fig. S2), and the lpxE-eptA deletion mutant was
complemented with lpxE-eptA (Fig. S2), as in both cases the wt
lipid A for these strains was found (calculated m/z, 1,716.3;
found m/z, 1,717).
Additional peaks measured at an m/z of 1,755 or 1,769 for
the lpxE  p-lpxE and the eptA  p-eptA strain are attrib-
uted to a minor lipid A variant with two phosphates present
and possibly with a classical GlcN-GlcN backbone, known to be
present in C. canimorsus 5 (calculatedm/z, 1,755.209; peak shift of
14m/z units due to acyl chain heterogeneity) (19). The two phos-
FIG 6 Mass spectrometric analysis of lipid A of the indicated strains as analyzed by MALDI-TOF MS in the positive-ion mode.
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phatesmight either be present as 1-phospho4=-phospho lipidAor as
1-pyrophosphate lipidA.Onthebasisof the1-pyrophosphate species
detected in various species (42), we hypothesize that the peaks mea-
sured at an m/z of 1,755 or 1,769 correspond to a 1-pyrophosphate
variant with a classical E. coli type GlcN-GlcN lipid A backbone. The
peak measured at an m/z of 1,725 for the lpxE  p-eptA strain is
similarly attributed to a bisphosphorylated species in combination
with an exchange of 17:0(3-OH) by 15:0(3-OH) (calculated m/z,
1,725.186).Thedetectionof thesepeaksexclusively incomplemented
mutants and the resulting changes in acyl chain preference and back-
bone structure, however, should be investigated further.
We conclude from these complementation experiments that
the eptA and lpxE mutations were nonpolar and that in the com-
plemented mutant strains, lpxE p-lpxE, eptA p-eptA, and
lpxE-eptA p-lpxE-eptA strains, the wt lipid A is reconstituted.
In the positive-ionmode,MS analysis confirmed the wt lipid A
(calculated m/z, 1,764.3; found m/z, 1,764) (Table 3 and Fig. 6).
Again peak “clusters” differing by 14 m/z units were found for
all samples. The 1-phospho lipid A variant has a calculatedm/z
of 1,720.2 [M-H2Na] in the positive-ion mode. The main
peaks for lpxE and lpxE-eptA deletion mutants were both
found at an m/z value of 1,722. This peak was absent in the
eptA deletion mutant strain. The eptA deletion mutant’s
main peak present at an m/z of 1,604 or 1,618 (peak shift of 14
m/z units due to acyl chain heterogeneity) corresponded to a
free hydroxy group that forms a reducing end in the lipid A
backbone and has been calculated to an m/z of 1,603.3 or
1,617.3. It is noteworthy that a peak at anm/z of 1,601 is found
in all samples in the positive-ion mode (and the corresponding
peak shifted by 14 m/z units). The presence of 1-dephospho
lipid A variants even in those mutants which contain the
1-phospho group has been assigned as artifacts well-known to
appear from the wt strains due to the acid hydrolysis conditions
necessary to liberate the lipid A from the phosphorylated Kdo
found in the core of C. canimorsus LPS (19, 34). These condi-
tions obviously lead to a partial dephosphorylation at position
1 of lipid A. The main peak from the 1-hydroxy lipid A cluster
for lpxE and lpxE-eptA deletion mutants was found at an
m/z of 1,601 and not at an m/z of 1,604/1,618 as predicted. We
assume that the peak at 1,604 m/z found in the eptA deletion
mutant is identical to peaks atm/z of 1,601 found in lpxE and
lpxE-eptA deletion mutants.
According to the proposed model, the major and representa-
tive lipid A molecule of the eptA mutant lacks any charged
group, and therefore, its pseudomolecular ion [MNa] can be
analyzed only in the positive-ionmode. In agreement with this, in
the positive-ion (but not the negative-ion)mode ofeptA lipid A,
the pseudomolecular ion [MNa] was detected. The ion [M-
H] detected in the negative-ionmode ofeptA lipid Awas likely
raised from incomplete dephosphorylated lipid A, resulting in
1-phospho lipid A. Notably, the [M-H] ion was not detected for
the eptAmutant in the positive-ion mode, possibly reflecting its
small proportion.
We further performed positive-ionmodeMS analysis on com-
plementedmutants (see Fig. S3 in the supplementalmaterial). The
lpxE strain could be complemented in trans with lpxE, as we
confirmed the wt lipid A for this strain (calculated m/z, 1,764.3;
found m/z, 1,764). The lpxE strain could not be complemented
in trans with eptA alone (Fig. S3), and the resulting strain showed
a main peak at anm/z of 1,722 (Fig. S3), matching the 1-phospho
lipid A variant predicted for lpxE (calculatedm/z, 1,720.2). The
eptA strain was complemented with eptA (Fig. S3), and the lpxE-
eptA deletionmutant was complementedwith lpxE-eptA (Fig. S3),
as in both cases, the wt lipid A for these strains was found (calcu-
latedm/z, 1,764.3; foundm/z, 1,764).
Additional peaksmeasured atm/z values of 1,803 and 1,817 for
the lpxE p-lpxE and the eptA p-eptA strain are attributed
to a minor bisphosphorylated lipid A backbone variant, probably
with a E. coli type classical GlcN-GlcN backbone known also to be
present in small amounts in C. canimorsus 5 (calculated m/z,
1,802.196; peak shift of 14m/z units due to acyl chain heterogene-
ity) (19) and that correlates with additional peaks observed in the
negative-ion mode MS analysis of these strains.
We conclude from these complementation experiments that
the eptA and lpxE mutations were nonpolar and that in the com-
plementedmutants,lpxE p-lpxE,eptA p-eptA, andlpxE-
eptA p-lpxE-eptA, the wt lipid A is reconstituted.
Overall, 1-phospho lipid A was validated as the main lipid A
variant in lpxE and lpxE-eptA deletion mutants. This confirms
that LpxE acts as a lipid A 1-phosphatase and further corroborates
the two-step enzymaticmechanism inwhich EptA is active only after
LpxE-dependent removal of the 1-phosphate on lipid A. In agree-
ment with endotoxicity and CAMP resistance, both 1-phospho and
1-dephospho lipid A variants were found present in the eptA dele-
tionmutant. This validates the functionof EptA as lipidAphosphoe-
thanolamine transferase and again supposes a two-step enzymatic
activity in which LpxE can dephosphorylate lipid A even in the ab-
sence of EptA. However, LpxE seems not to dephosphorylate every
lipid A in the absence of EptA, which is reflected by the 1-phospho
lipid A species identified in theeptA deletionmutant.
The lipid A modification described in this work clearly repre-
sents a virulence factor, since it dramatically reduces recognition
and killing by the host’s innate immune system. However, human
infections are rare events and dead ends for C. canimorsus. Thus,
we can envision that the lipid A modification most likely evolved
as a factor favoring the adaptation of C. canimorsus to its natural
niche, the dog’s mouth.
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